ZEVIPTO
Live / Registered — Registered (as of 18 Feb 2025)
What this means for you
Registered since 18 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79386352
- Registration number
- 7691329
- Mark type
- Stylized text
- Filed
- 08 Nov 2023
- Published for opposition
- 31 Dec 2024
- Registered
- 18 Feb 2025
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all of the above with the exception of pharmaceuticals for the prevention and treatment of central nervous system diseases and disorders
Owner
- Novartis AG, CH
- Novartis AG, CH
- Novartis AG, CH
Prosecution history
- 19 Sept 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 01 Sept 2025 — FINAL DISPOSITION NOTICE SENT TO IB
- 01 Sept 2025 — FINAL DISPOSITION PROCESSED
- 13 Jun 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 27 May 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 27 May 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 18 May 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 18 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 31 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Dec 2024 — PUBLISHED FOR OPPOSITION
- 25 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Nov 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Nov 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE